MX2012003078A - Nuevos peptidos aislados de veneno de araña y sus usos. - Google Patents

Nuevos peptidos aislados de veneno de araña y sus usos.

Info

Publication number
MX2012003078A
MX2012003078A MX2012003078A MX2012003078A MX2012003078A MX 2012003078 A MX2012003078 A MX 2012003078A MX 2012003078 A MX2012003078 A MX 2012003078A MX 2012003078 A MX2012003078 A MX 2012003078A MX 2012003078 A MX2012003078 A MX 2012003078A
Authority
MX
Mexico
Prior art keywords
spider venom
novel peptides
peptides isolated
isolated
venom
Prior art date
Application number
MX2012003078A
Other languages
English (en)
Inventor
Alon Meir
Ronit Simcha Cherki
Ela Kolb
Yael Langut
Nissim Bajayo
Original Assignee
Alomone Preclinical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alomone Preclinical Ltd filed Critical Alomone Preclinical Ltd
Publication of MX2012003078A publication Critical patent/MX2012003078A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Insects & Arthropods (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La materia actualmente descrita se refiere a péptidos de veneno de araña aislados que se usan como potentes y selectivos bloqueadores del canal iónico y a una composición y a métodos para el tratamiento del dolor.
MX2012003078A 2009-09-15 2010-09-13 Nuevos peptidos aislados de veneno de araña y sus usos. MX2012003078A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27233609P 2009-09-15 2009-09-15
PCT/IB2010/002275 WO2011033358A2 (en) 2009-09-15 2010-09-13 Novel peptides isolated from spider venom, and uses thereof

Publications (1)

Publication Number Publication Date
MX2012003078A true MX2012003078A (es) 2012-08-03

Family

ID=43731158

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003078A MX2012003078A (es) 2009-09-15 2010-09-13 Nuevos peptidos aislados de veneno de araña y sus usos.

Country Status (12)

Country Link
US (1) US8399026B2 (es)
EP (1) EP2504023B1 (es)
JP (1) JP5555891B2 (es)
CN (1) CN102573884B (es)
AR (1) AR078374A1 (es)
AU (1) AU2010296994B2 (es)
BR (1) BR112012005860A2 (es)
CA (1) CA2774350A1 (es)
IL (1) IL218382A0 (es)
MX (1) MX2012003078A (es)
SG (1) SG179101A1 (es)
WO (1) WO2011033358A2 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018085954A1 (es) * 2016-11-14 2018-05-17 Universidad De Antofagasta Peptidos con actividad antimicrobiana

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014509859A (ja) * 2011-03-16 2014-04-24 アムジエン・インコーポレーテツド １７ｎａｖ１．３およびｎａｖ１．７の強力かつ選択的阻害剤
AU2012300197B2 (en) * 2011-08-24 2018-01-18 The University Of Queensland Pest-controlling agents isolated from spider venom and uses thereof
US10414808B2 (en) 2012-05-18 2019-09-17 Janssen Biotech, Inc. Huwentoxin-IV variants and methods of use
EP3973981A1 (en) 2012-05-18 2022-03-30 Janssen Biotech, Inc. Huwentoxin-iv variants and methods of use
US9102751B2 (en) 2012-05-18 2015-08-11 Janssen Biotech, Inc. Huwentoxin-IV variants and methods of use
JP6086378B2 (ja) * 2012-11-30 2017-03-01 国立大学法人お茶の水女子大学 組み換えヒト膵臓リパーゼの調製方法
US10344060B2 (en) 2013-03-12 2019-07-09 Amgen Inc. Potent and selective inhibitors of Nav1.7
US9636418B2 (en) 2013-03-12 2017-05-02 Amgen Inc. Potent and selective inhibitors of NAV1.7
KR20160064192A (ko) 2013-10-03 2016-06-07 얀센 바이오테크 인코포레이티드 프로톡신-ii 변이체 및 사용 방법
GB201410108D0 (en) * 2014-06-06 2014-07-23 Univ Manchester Peptides, and methods and apparatus utilising same
MA41642A (fr) 2015-03-03 2018-01-09 Janssen Biotech Inc Variants de protoxine ii et méthodes d'utilisation
EP3277304B1 (en) 2015-04-02 2021-08-04 Janssen Biotech, Inc. Protoxin-ii variants and methods of use
CN107141344A (zh) * 2017-06-01 2017-09-08 长沙沁才生物科技有限公司 一种新型天然活性多肽spkp‑xi
CN107141343A (zh) * 2017-06-01 2017-09-08 长沙沁才生物科技有限公司 一种活性多肽spkp‑xi的制备方法
CN107163124A (zh) * 2017-06-22 2017-09-15 长沙沁才生物科技有限公司 SPNP‑IX在制备Nav1.3通道抑制剂中的应用
CN107496904B (zh) * 2017-09-21 2020-03-17 中南大学 多肽Lycosin-Ⅰ在制备抗炎和抗弓形虫药物中的应用
CN108047323B (zh) * 2017-12-20 2022-04-12 深圳羽众医药科技有限公司 一种固相片段法合成GpTx-1及其类似物和合成方法
WO2022066767A2 (en) * 2020-09-23 2022-03-31 Aldevron, Llc Potent and selective inhibitors of nav1.7

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
AU2698684A (en) 1983-07-01 1985-02-07 Battelle Memorial Institute Polypeptide biodegradable et son utilisation pour le relargage progressif de medicaments
US5417986A (en) 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5776896A (en) * 1996-01-03 1998-07-07 Zeneca Limited Analgesic peptides from venom of grammostola spatulata and use thereof
CN1133461C (zh) * 2000-04-11 2004-01-07 厦门北大之路生物工程有限公司 虎纹捕鸟蜘蛛毒素提取物在制备镇痛药物中的应用
US6727226B2 (en) * 2000-07-21 2004-04-27 University Of Utah Research Foundation Mu-conopeptides
WO2004050688A1 (en) * 2002-12-02 2004-06-17 Xenome Ltd NOVEL χ-CONOTOXIN PEPTIDES (-II)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018085954A1 (es) * 2016-11-14 2018-05-17 Universidad De Antofagasta Peptidos con actividad antimicrobiana

Also Published As

Publication number Publication date
CA2774350A1 (en) 2011-03-24
JP2013504318A (ja) 2013-02-07
WO2011033358A2 (en) 2011-03-24
EP2504023A2 (en) 2012-10-03
WO2011033358A3 (en) 2011-07-14
CN102573884B (zh) 2015-01-14
AU2010296994B2 (en) 2013-09-19
JP5555891B2 (ja) 2014-07-23
BR112012005860A2 (pt) 2017-01-31
IL218382A0 (en) 2012-04-30
SG179101A1 (en) 2012-05-30
US20110065647A1 (en) 2011-03-17
US8399026B2 (en) 2013-03-19
EP2504023A4 (en) 2013-04-10
CN102573884A (zh) 2012-07-11
EP2504023B1 (en) 2015-07-15
AR078374A1 (es) 2011-11-02
AU2010296994A1 (en) 2012-04-19

Similar Documents

Publication Publication Date Title
SG179101A1 (en) Novel peptides isolated from spider venom, and uses thereof
EA201390967A1 (ru) Специфические для грамположительных бактерий связывающие соединения
MX347852B (es) Cepas de bradirrizobio.
WO2013151668A3 (en) Modified polynucleotides for the production of secreted proteins
MY179933A (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereof
MX2011008262A (es) Espiroamidas sustituidas como moduladores de b1r:.
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
SG10201804385YA (en) Stimulus responsive polymers for the purification of biomolecules
MX2013000958A (es) Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma.
NZ706052A (en) Romidepsin solid forms and uses thereof
MX2011011272A (es) Procesos e intermediarios.
MX2015015188A (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
MX2011008621A (es) Proceso para la purificacion de lipopeptidos.
WO2012065110A3 (en) S-protected cysteine analogs and related compounds
NZ707091A (en) Use of a pvdf membrane to purify cell-binding agent cytotoxic agent conjugates
MX2013002784A (es) Heteroarilos fusionados y sus usos.
WO2012015999A3 (en) Process for the preparation of imatinib mesylate
PL2545019T3 (pl) Sposób i urządzenie do destylacyjnego otrzymywania czystego 1,3-butadienu z surowego 1,3-butadienu
HK1163659A1 (en) Process for the preparation of ajoene
MX357166B (es) Anticuerpos que se unen a notum pectinacetilesterasa.
IN2013MN00733A (es)
IN2015DN03203A (es)
MX2011012623A (es) Construcciones de casb7439.
WO2011029536A3 (de) Verwendung von cyclischen ketoenolen gegen pflanzenpathogene bakterien
MY156873A (en) Novel forms of a multicyclic compound

Legal Events

Date Code Title Description
FG Grant or registration